Clinical Trials Directory

Trials / Completed

CompletedNCT02593422

Writing About Experiences With Ovarian Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
University of Maryland, College Park · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This online study aims to understand whether writing about one's experiences with ovarian cancer may be beneficial for psychological and physical wellbeing in women with a history of ovarian cancer. Investigators are also interested in studying how certain individual characteristics may impact the effectiveness of writing. Participants will be asked to complete an initial survey (15 min), followed by writing about their experiences with ovarian cancer on four occasions (20 - 25 min each), over the course of two weeks. A final survey (10 min) will be completed one month afterwards.

Detailed description

The purpose of this randomized controlled experiment is to examine the effects of writing about experiences with ovarian cancer on psychological and physical outcomes in English-speaking women with a history of ovarian cancer. It will also examine how certain individual characteristics may impact the effectiveness of the writing interventions for different women. After completing an initial survey, women will be asked to write about their experiences with ovarian cancer on 4 separate occasions of 20-25 min each in the course of 2 weeks. A final survey will be completed one month after the last writing session. The entire study will be conducted online.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExpressive WritingParticipants will be asked to write about their deepest thoughts and emotions about their experience with ovarian cancer
BEHAVIORALFact Writing (Control)Participants will be asked to write about the facts of their experience with ovarian cancer

Timeline

Start date
2015-04-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2015-11-02
Last updated
2022-05-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02593422. Inclusion in this directory is not an endorsement.